Advertisement Japan university develops technology to predict anti-cancer products - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Japan university develops technology to predict anti-cancer products

Professor Ona's laboratory at Kyushu University has developed high sensitive, label-free and non-invasive cell-based sensing technology for prediction of anti-cancer and anti-metabolic syndrome compounds in their physiological concentrations.

This technology determines the efficacy of dynamic cellular reaction against target compounds within one hour after the compound is added.

According to the comany, the method will contribute to compound screening for personalized chemotherapy or preventive medicines including anti-cancer, Alzheimer disease, aging (skin care), diabetes, pro-fat burning, metabolism, hair restoration and body temperature.

Kyushu University Professor Toshihiro Ona said they developed surface plasmon resonance sensor (SPR), for biomolecular interaction analysis, besides establishing the method for mitochondrial membrane potential monitor.

The university intends to set up a venture business to manufacture and sell a multi-sample device, to sell patent for interactive combination of compounds.